BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11892251)

  • 1. Opportunities for the use of lentiviral vectors in human gene therapy.
    Galimi F; Verma IM
    Curr Top Microbiol Immunol; 2002; 261():245-54. PubMed ID: 11892251
    [No Abstract]   [Full Text] [Related]  

  • 2. Lentiviruses as vectors for CNS diseases.
    Déglon N; Aebischer P
    Curr Top Microbiol Immunol; 2002; 261():191-209. PubMed ID: 11892248
    [No Abstract]   [Full Text] [Related]  

  • 3. Lentiviral vectors for gene therapy of HIV-induced disease.
    Amado RG; Chen IS
    Curr Top Microbiol Immunol; 2002; 261():229-43. PubMed ID: 11892250
    [No Abstract]   [Full Text] [Related]  

  • 4. Trial watch: Clinical trial boost for lentiviral gene therapy.
    Flight MH
    Nat Rev Drug Discov; 2013 Sep; 12(9):654. PubMed ID: 23989781
    [No Abstract]   [Full Text] [Related]  

  • 5. Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications.
    Wong LF; Goodhead L; Prat C; Mitrophanous KA; Kingsman SM; Mazarakis ND
    Hum Gene Ther; 2006 Jan; 17(1):1-9. PubMed ID: 16409120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human CD34+ hematopoietic progenitor cell-directed lentiviral-mediated gene therapy in a xenotransplantation model of lysosomal storage disease.
    Hofling AA; Devine S; Vogler C; Sands MS
    Mol Ther; 2004 Jun; 9(6):856-65. PubMed ID: 15194052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial.
    Sessa M; Lorioli L; Fumagalli F; Acquati S; Redaelli D; Baldoli C; Canale S; Lopez ID; Morena F; Calabria A; Fiori R; Silvani P; Rancoita PM; Gabaldo M; Benedicenti F; Antonioli G; Assanelli A; Cicalese MP; Del Carro U; Sora MG; Martino S; Quattrini A; Montini E; Di Serio C; Ciceri F; Roncarolo MG; Aiuti A; Naldini L; Biffi A
    Lancet; 2016 Jul; 388(10043):476-87. PubMed ID: 27289174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Therapy for Rare Central Nervous System Diseases Comes to Age.
    Aubourg P
    Endocr Dev; 2016; 30():141-6. PubMed ID: 26684481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lentiviral vectors--the promise of gene therapy within reach?
    Amado RG; Chen IS
    Science; 1999 Jul; 285(5428):674-6. PubMed ID: 10454923
    [No Abstract]   [Full Text] [Related]  

  • 10. Development and applications of non-HIV-based lentiviral vectors in neurological disorders.
    Valori CF; Ning K; Wyles M; Azzouz M
    Curr Gene Ther; 2008 Dec; 8(6):406-18. PubMed ID: 19075624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentiviral vectors for the central nervous system.
    Armandola E
    MedGenMed; 2004 Sep; 6(3):17. PubMed ID: 15520640
    [No Abstract]   [Full Text] [Related]  

  • 12. Lentiviral vectors for treating and modeling human CNS disorders.
    Azzouz M; Kingsman SM; Mazarakis ND
    J Gene Med; 2004 Sep; 6(9):951-62. PubMed ID: 15352068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosafety challenges for use of lentiviral vectors in gene therapy.
    Rothe M; Modlich U; Schambach A
    Curr Gene Ther; 2013 Dec; 13(6):453-68. PubMed ID: 24195603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luigi Naldini on His Lifelong Involvement with the Development of Gene Therapy.
    Wilson JM
    Hum Gene Ther Clin Dev; 2016 Sep; 27(3):83-6. PubMed ID: 27556334
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene therapy: Industrial strength.
    Bender E
    Nature; 2016 Sep; 537(7619):S57-9. PubMed ID: 27602741
    [No Abstract]   [Full Text] [Related]  

  • 16. Skeletal response to lentiviral mediated gene therapy in a mouse model of MPS VII.
    Macsai CE; Derrick-Roberts AL; Ding X; Zarrinkalam KH; McIntyre C; Anderson PH; Anson DS; Byers S
    Mol Genet Metab; 2012 Jun; 106(2):202-13. PubMed ID: 22525091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentiviral hematopoietic stem cell gene therapy in inherited metabolic disorders.
    Wagemaker G
    Hum Gene Ther; 2014 Oct; 25(10):862-5. PubMed ID: 25184354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy of the central nervous system: general considerations on viral vectors for gene transfer into the brain.
    Serguera C; Bemelmans AP
    Rev Neurol (Paris); 2014 Dec; 170(12):727-38. PubMed ID: 25459120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of a tCD25 preselective combination anti-HIV lentiviral vector in human hematopoietic stem and progenitor cells.
    Barclay SL; Yang Y; Zhang S; Fong R; Barraza A; Nolta JA; Torbett BE; Abedi M; Bauer G; Anderson JS
    Stem Cells; 2015 Mar; 33(3):870-9. PubMed ID: 25524029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonprimate lentiviral vectors.
    Curran MA; Nolan GP
    Curr Top Microbiol Immunol; 2002; 261():75-105. PubMed ID: 11892254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.